Search research articles
Contact Us
Filters
Showing results (11-20 of 105) with videos related to
Page
of 11
Sort By:
Expert Opinion on Drug Safety
|
August 9, 2003
Safety of adeno-associated virus gene therapy vectors: a current evaluation
Paul E Monahan, Karin Jooss, Mark S Sands
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2002
VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients
Pampee P Young, A Alex Hofling, Mark S Sands
Neuroscience Letters
|
March 26, 2021
Krabbe disease: New hope for an old disease
Allison M Bradbury, Ernesto R Bongarzone, Mark S Sands
Experimental Neurology
|
June 12, 2004
VEGF disrupts the neonatal blood-brain barrier and increases life span after non-ablative BMT in a murine model of congenital neurodegeneration caused by a lysosomal enzyme deficiency
Pampee P Young, Corinne R Fantz, Mark S Sands
Human Gene Therapy
|
March 16, 2017
Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models
Randy J Chandler, Mark S Sands, Charles P Venditti
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 15, 2004
Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease
A Alex Hofling, Steven Devine, Carole Vogler, et al.
Human Molecular Genetics
|
March 23, 2011
Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?
Jacqueline A Hawkins-Salsbury, Adarsh S Reddy, Mark S Sands
Biochimica Et Biophysica Acta
|
June 11, 2013
Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease)
Jacqueline A Hawkins-Salsbury, Jonathan D Cooper, Mark S Sands
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 8, 2003
Biodistribution and efficacy of donor T lymphocytes in a murine model of lysosomal storage disease
Pampee P Young, Carole Vogler, A Alex Hofling, et al.
Blood
|
October 31, 2002
Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease
A Alex Hofling, Carole Vogler, Michael H Creer, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 105) with videos related to
Sort By:
Page
of 11
Expert Opinion on Drug Safety
|
August 9, 2003
Safety of adeno-associated virus gene therapy vectors: a current evaluation
Paul E Monahan, Karin Jooss, Mark S Sands
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2002
VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients
Pampee P Young, A Alex Hofling, Mark S Sands
Neuroscience Letters
|
March 26, 2021
Krabbe disease: New hope for an old disease
Allison M Bradbury, Ernesto R Bongarzone, Mark S Sands
Experimental Neurology
|
June 12, 2004
VEGF disrupts the neonatal blood-brain barrier and increases life span after non-ablative BMT in a murine model of congenital neurodegeneration caused by a lysosomal enzyme deficiency
Pampee P Young, Corinne R Fantz, Mark S Sands
Human Gene Therapy
|
March 16, 2017
Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models
Randy J Chandler, Mark S Sands, Charles P Venditti
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 15, 2004
Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease
A Alex Hofling, Steven Devine, Carole Vogler, et al.
Human Molecular Genetics
|
March 23, 2011
Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?
Jacqueline A Hawkins-Salsbury, Adarsh S Reddy, Mark S Sands
Biochimica Et Biophysica Acta
|
June 11, 2013
Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease)
Jacqueline A Hawkins-Salsbury, Jonathan D Cooper, Mark S Sands
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 8, 2003
Biodistribution and efficacy of donor T lymphocytes in a murine model of lysosomal storage disease
Pampee P Young, Carole Vogler, A Alex Hofling, et al.
Blood
|
October 31, 2002
Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease
A Alex Hofling, Carole Vogler, Michael H Creer, et al.
Page
of 11